Memorial Sloan Kettering Cancer Center

See the following -

A Hidden Factor in Stroke Severity: the Microbes in Your Gut

Jordana Cepelwicz | Scientific American | March 30, 2016

The bacteria that inhabit our guts have become key players for neuroscientists. A growing body of research links them to a wide array of mental and neurological disorders—from anxiety and depression to schizophrenia and Alzheimer’s disease. Now a study in mice published this week in Nature Medicine suggests that striking the right microbial balance could cause changes in the immune system that significantly reduce brain damage after a stroke—the second leading cause of both death and disability for people around the globe. (Scientific American is part of Springer Nature.)...

Read More »

On the Financial Conflicts of Interests of Medical Societies and Rising Drug Prices

The notion that health care prices are high and are rising continuously in the US should hardly be novel...We first posted about high drug prices in July, 2005, with the example of BilDil...But only a few days later we noted that three cancer costs had yearly costs in the five figures, and one, Erbitux, cost as much as $100,000.  Most amazingly we noted that Thalidomid was priced at $25,000  a year...Since then, the ridiculously high prices of many tests and treatments, but most notably new drugs and devices, has been so widely covered, our discussion has been limited to special cases.,,

Read More »

Parker Foundation Invests $250 Million in Open and Collaborative Cancer Research to Accelerate Innovation

Press Release | The Parker Foundation | April 13, 2016

The Parker Foundation today announced a $250 million grant to launch the Parker Institute for Cancer Immunotherapy, a collaboration between many of the country's best scientists, clinicians and industry partners to lead an unprecedented cancer immunotherapy research effort. The gift is the largest single contribution ever made to the field of immunotherapy. The Parker Institute's goal is to accelerate the development of breakthrough immune therapies capable of turning cancer into a curable disease by ensuring the coordination and collaboration of the field's top researchers and quickly translating their findings into patient treatments.

Read More »

Building a sustainable community around cBioPortal

Event Details
Type: 
Seminar/Webinar
Date: 
July 22, 2015 - 11:00am - 12:30pm

The cBioPortal for Cancer Genomics provides visualization, analysis and download of large-scale cancer genomics data sets. The code, which was developed at Memorial Sloan Kettering Cancer Center has recently been put into the public domain under a GNU Affero General Public License v3.0, and the Pistoia Alliance is exploring ways to build a sustainable community around it. Further project details can be found in IP3.The Pistoia Alliance will be holding a webinar to bring perspectives from the original developers, academic and pharma users, and a commercial open source solution provider, followed by a Q&A session.

Read More »